Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

Iambic Therapeutics, a biotechnology company backed by Nvidia and the Qatar Investment Authority (QIA), has officially filed for an initial public offering (IPO) in the United States.

The move comes amid an ongoing sector-wide biotech boom, highlighting continued investor appetite and market activity for life sciences firms with high-profile backers.